Get informed when a big investor buys or sells
+ FollowUndervalued by 197.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $50.09 Billion |
|---|---|
| Enterprise Value | $49.98 Billion |
| Annual dividend | $198.62 |
| Dividend yield | 4.38% |
| Earnings per Share | $4.95 |
| Beta | -0.2 |
| Outstanding Shares | 11,188,000 |
| P/E Ratio | 13.07 |
|---|---|
| PEG | -17.76 |
| Price to Sales | 56.67 |
| Price to Book Ratio | 75.88 |
| Enterprise Value to Revenue | 56.45 |
| Enterprise Value to EBIT | 1042.4 |
| Enterprise Value to Net Income | 1284 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.11 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Ilex Medical Ltd. engages in medical diagnostics field. It operates through the following segments: Medical Laboratory Equipment and Diagnostics Materials, Medical Equipment, and Inhalation Devices. The Medical Laboratory Equipment and D...